News

• 29 Mar, 2023
  Spago Nanomedical publishes the annual report for 2022
• 29 Mar, 2023
  Spago Nanomedical publicerar årsredovisningen för 2022
• 2 Feb, 2023
  Spago Nanomedical bokslutskommuniké januari-december 2022
• 2 Feb, 2023
  Spago Nanomedical year-end report January-December, 2022
• 10 Jan, 2023
  Spago Nanomedical publicerar vetenskaplig artikel med positiva prekliniska data med Tumorad® som behandling av solida tumörer
• 10 Jan, 2023
  Spago Nanomedical publishes scientific paper on positive preclinical data with Tumorad® as treatment of solid tumors
• 23 Dec, 2022
  Spago Nanomedical terminates liquidity guarantee
• 23 Dec, 2022
  Spago Nanomedical avslutar avtal om likvididtetsgaranti
• 8 Dec, 2022
  Första patienten doserad i Spago Nanomedicals kliniska fas IIa-studie i endometrios
• 8 Dec, 2022
  First patient dosed in Spago Nanomedical’s endometriosis Phase IIa clinical study